Inside Heart Rhythm 2025 with Pharmaron
Capabilities
Pharmaron participated in the Heart Rhythm 2025 Annual Meeting, held April 24–27 at the San Diego Convention Center. This premier event brought together cardiac device technology and electrophysiology leaders, creating a platform for meaningful discussion and knowledge exchange.
At booth #620, our team shared insights into our preclinical surgical and interventional research capabilities, focusing on cardiovascular and electrophysiology-related device development. A team with deep expertise in study design, execution, and regulatory expectations backs Pharmaron. All large animal medical device testing is conducted in our 65,000 sq. ft., AAALAC-accredited, GLP-compliant, and NIH-assured laboratory in San Diego, CA. These accreditations reflect our commitment to maintaining rigorous quality standards while supporting studies from early feasibility through to safety evaluations.
“We were honored to participate in HRS 2025, where we had the opportunity to showcase Pharmaron’s comprehensive cardiovascular research services, engage with our valued clients, and connect with new partners. Events like HRS are essential for driving collaboration and innovation in advancing cardiovascular health.”
— Scott Barnhill, Senior Director, Business Development – Medical Device and Ophthalmology
It was a valuable few days connecting with everyone at Heart Rhythm 2025. We truly appreciated the opportunity to engage in thoughtful discussions about the future of electrophysiology and cardiac device advancements. Thank you to everyone who visited our booth — we look forward to continuing to support innovation in this critical field.
Related Resources:
Explore our new San Diego CRO for medical device testing services.
